Literature DB >> 15962513

Mechanisms of the blood-brain barrier disruption in HIV-1 infection.

Michal Toborek1, Yong Woo Lee, Govinder Flora, Hong Pu, Ibolya E András, Edward Wylegala, Bernhard Hennig, Avindra Nath.   

Abstract

(1) Alterations of brain microvasculature and the disruption of the blood-brain barrier (BBB) integrity are commonly associated with human immunodeficiency virus type 1 (HIV-1) infection. These changes are most frequently found in human immunodeficiency virus-related encephalitis (HIVE) and in human immunodeficiency virus-associated dementia (HAD). (2) It has been hypothesized that the disruption of the BBB occurs early in the course of HIV-1 infection and can be responsible for HIV-1 entry into the CNS. (3) The current review discusses the mechanisms of injury to brain endothelial cells and alterations of the BBB integrity in HIV-infection with focus on the vascular effects of HIV Tat protein. In addition, this review describes the mechanisms of the BBB disruption due to HIV-1 or Tat protein interaction with selected risk factors for HIV infection, such as substance abuse and aging.

Entities:  

Mesh:

Year:  2005        PMID: 15962513     DOI: 10.1007/s10571-004-1383-x

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  127 in total

1.  HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim.

Authors:  Dan Chen; Michael Wang; Sharleen Zhou; Qiang Zhou
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

2.  Increased human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells induced by ethanol: potential immunopathogenic mechanisms.

Authors:  O Bagasra; S E Bachman; L Jew; R Tawadros; J Cater; G Boden; I Ryan; R J Pomerantz
Journal:  J Infect Dis       Date:  1996-03       Impact factor: 5.226

Review 3.  Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome.

Authors:  S A Lipton; H E Gendelman
Journal:  N Engl J Med       Date:  1995-04-06       Impact factor: 91.245

4.  Fibronectin modulates endothelial response to HIV type 1 Tat.

Authors:  U Cavallaro; M Mariotti; Z H Wu; M R Soria; J A Maier
Journal:  AIDS Res Hum Retroviruses       Date:  1997-10-10       Impact factor: 2.205

5.  Influence of adhesion molecule expression by human brain microvessel endothelium on cancer cell adhesion.

Authors:  J Brayton; Z Qing; M N Hart; J C VanGilder; Z Fabry
Journal:  J Neuroimmunol       Date:  1998-08-14       Impact factor: 3.478

6.  Recombinant human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially up-regulates IL-6 and TGF-beta 1 mRNA expression and protein synthesis in peripheral blood monocytes.

Authors:  D Gibellini; G Zauli; M C Re; D Milani; G Furlini; E Caramelli; S Capitani; M La Placa
Journal:  Br J Haematol       Date:  1994-10       Impact factor: 6.998

7.  Vascular changes in the cerebral cortex in HIV-1 infection. II. An immunohistochemical and lectinhistochemical investigation.

Authors:  A Büttner; P Mehraein; S Weis
Journal:  Acta Neuropathol       Date:  1996-07       Impact factor: 17.088

8.  Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease.

Authors:  E J Singer; K Syndulko; B Fahy-Chandon; P Schmid; A Conrad; W W Tourtellotte
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-03

9.  Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain.

Authors:  Govinder Flora; Yong Woo Lee; Avindra Nath; Bernhard Hennig; William Maragos; Michal Toborek
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

Review 10.  Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration.

Authors:  E Dejana; R Spagnuolo; G Bazzoni
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

View more
  115 in total

1.  Soluble membrane attack complex in the blood and cerebrospinal fluid of HIV-infected individuals, relationship to HIV RNA, and comparison with HIV negatives.

Authors:  Albert M Anderson; Theresa N Schein; Aley Kalapila; Lillin Lai; Drenna Waldrop-Valverde; Raeanne C Moore; Donald Franklin; Scott L Letendre; Scott R Barnum
Journal:  J Neuroimmunol       Date:  2017-07-23       Impact factor: 3.478

Review 2.  Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier.

Authors:  Michelle A Erickson; Kenji Dohi; William A Banks
Journal:  Neuroimmunomodulation       Date:  2012-01-11       Impact factor: 2.492

Review 3.  Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances.

Authors:  Wei-Ye Liu; Zhi-Bin Wang; Li-Chao Zhang; Xin Wei; Ling Li
Journal:  CNS Neurosci Ther       Date:  2012-06-12       Impact factor: 5.243

Review 4.  Tight junctions in the testis: new perspectives.

Authors:  Dolores D Mruk; C Y Cheng
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

5.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 6.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

7.  Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection.

Authors:  Qingqing Chai; Wen Q He; Ming Zhou; Huijun Lu; Zhen F Fu
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

8.  Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.

Authors:  Fang Li; Yueyun Wang; Lan Yu; Shengbo Cao; Ke Wang; Jiaolong Yuan; Chong Wang; Kunlun Wang; Min Cui; Zhen F Fu
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

9.  The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.

Authors:  Randall L Davis; Daniel J Buck; Neda Saffarian; Craig W Stevens
Journal:  J Neuroimmunol       Date:  2007-05-01       Impact factor: 3.478

10.  PPARalpha and PPARgamma attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities.

Authors:  Wen Huang; Sung Yong Eum; Ibolya E András; Bernhard Hennig; Michal Toborek
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.